• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

    10/15/24 6:50:00 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care
    Get the next $SOLV alert in real time by email

    ST. PAUL, Minn., Oct. 15, 2024 /PRNewswire/ -- Solventum (NYSE:SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets close. The company will also host a conference call that day at 4:30 p.m. Eastern Time to discuss its third quarter financial results and provide an update on its business.

    Solventum Logo (PRNewsfoto/3M Healthcare US Opco  LLC)

    The conference call can be accessed via audio webcast at investors.solventum.com or by dialing (800) 715-9871 within the U.S. or +1 (646) 307-1963 for international callers using the conference ID #6342275.

    A replay of the webcast, along with the earnings press release, presentation slides and supplemental financial disclosures, will be available at the same link on the Investor Relations section of the company's website.

    About Solventum

    At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/solventum-to-report-third-quarter-2024-financial-results-and-host-conference-call-on-november-7-2024-302275624.html

    SOURCE Solventum

    Get the next $SOLV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SOLV

    DatePrice TargetRatingAnalyst
    6/6/2025Sector Weight
    KeyBanc Capital Markets
    5/19/2025$87.00Neutral → Overweight
    Piper Sandler
    12/4/2024$70.00Neutral
    Mizuho
    10/8/2024$82.00Buy
    Stifel
    10/7/2024$71.00Neutral
    Piper Sandler
    9/26/2024Peer Perform
    Wolfe Research
    9/5/2024Neutral
    BTIG Research
    6/24/2024Hold
    Argus
    More analyst ratings

    $SOLV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Solventum Named a Best Company to Work for by U.S. News & World Report

      Recognized among the top 25 percent of companies in healthcare and research, and top 25 percent of companies in the Midwest in just 14 months as a new company Award highlights success in phase one of Solventum's three-phased Transformation Plan ST. PAUL, Minn., June 18, 2025  /PRNewswire/ -- Solventum (NYSE:SOLV), a global leader in innovative medical technology and solutions, today announced U.S. News & World Report has named the company among its 2025-2026 list of Best Companies to Work For, earning top honors in three categories: Best Companies OverallHealth Care and Resear

      6/18/25 10:00:00 AM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

      ST. PAUL, Minn., June 3, 2025 /PRNewswire/ -- Solventum (NYSE:SOLV) announced today its executives will participate in a fireside chat at the Goldman Sachs 46th Annual Global Health Care Conference on Tuesday, June 10, 2025, beginning at approximately 4:00 p.m. EDT in Miami, FL. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About SolventumAt Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' tou

      6/3/25 4:05:00 PM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • Solventum Reports First Quarter 2025 Financial Results

      Reported sales increased 2.6%; organic sales increased 4.3%Increases full year organic sales growth outlook by 50 bps to +1.5% to +2.5%ST. PAUL, Minn., May 8, 2025 /PRNewswire/ -- Solventum (NYSE:SOLV) today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Sales increased 2.6% to $2.1 billion; up 4.3% on an organic basisGAAP diluted earnings per share of $0.78; adjusted diluted earnings per share of $1.34Operating cash flow of $29 million; free cash flow of $(80) million"Our first quarter fiscal year 2025 results reflect soli

      5/8/25 4:05:00 PM ET
      $SOLV
      Medical/Dental Instruments
      Health Care

    $SOLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KeyBanc Capital Markets initiated coverage on Solventum Corporation

      KeyBanc Capital Markets initiated coverage of Solventum Corporation with a rating of Sector Weight

      6/6/25 8:37:20 AM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • Solventum Corporation upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Solventum Corporation from Neutral to Overweight and set a new price target of $87.00

      5/19/25 8:47:51 AM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • Mizuho initiated coverage on Solventum Corporation with a new price target

      Mizuho initiated coverage of Solventum Corporation with a rating of Neutral and set a new price target of $70.00

      12/4/24 7:49:27 AM ET
      $SOLV
      Medical/Dental Instruments
      Health Care

    $SOLV
    SEC Filings

    See more
    • SEC Form SD filed by Solventum Corporation

      SD - Solventum Corp (0001964738) (Filer)

      5/30/25 4:09:35 PM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by Solventum Corporation

      10-Q - Solventum Corp (0001964738) (Filer)

      5/9/25 12:24:15 PM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • Solventum Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Solventum Corp (0001964738) (Filer)

      5/8/25 4:13:51 PM ET
      $SOLV
      Medical/Dental Instruments
      Health Care

    $SOLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Solventum Corporation

      SC 13G/A - Solventum Corp (0001964738) (Subject)

      11/12/24 5:47:11 PM ET
      $SOLV
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Solventum Corporation

      SC 13G/A - Solventum Corp (0001964738) (Subject)

      11/4/24 1:47:43 PM ET
      $SOLV
      Medical/Dental Instruments
      Health Care